Increasing Information Value, Making the Business Environment Visible,
and Supporting Customersf Decision-Making and Strategic Planning
The market environment surrounding the pharmaceutical and healthcare
products industry is changing at an unprecedented pace and scale, both
inside and outside of Japan.
The Japanese market is poised for major changes under a new policy
framework, with revisions to National Health Insurance drug prices
designed to promote the use of generics and advance the development of new
drugs.
From a global perspective as well, changes are taking place that will push
industry firms to rearrange their management strategy priorities, including
healthcare systems reforms in the major markets of the West and the growth
of so-called gpharmerging marketsh in the emerging economies.
Amid these changes in the market environment, in addition to the products
and services we have been providing our customers - which mostly
contribute to advancing sales strategies based on pharmaceuticals and
healthcare market data - IMS Japan is actively developing and promoting
new products and services to support the drafting of strategies for the
successful market release of new products as well as the construction of new
business models that can adapt to market changes.
Moreover, to support the global strategies of our customers, we are
strengthening our ties with IMS offices around the world and providing
optimal solutions for each changing market.
Looking forward, IMS Japan will reinforce our collaboration with medical
institutions, academic bodies, government organs, and other stakeholders,
increase the value of the information we supply, and support our customersf
decision-making and strategic planning processes.
We express our sincere gratitude for your warm support, and ask for your
continued encouragement and guidance.
Norihiko Minato
President and Representative Director
IMS JAPAN K.K.
